Dale Danilewitz Sells 3,121 Shares of AmerisourceBergen Corp. (NYSE:ABC) Stock

AmerisourceBergen Corp. (NYSE:ABC) insider Dale Danilewitz sold 3,121 shares of the firm’s stock in a transaction that occurred on Tuesday, January 2nd. The stock was sold at an average price of $92.12, for a total transaction of $287,506.52. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Dale Danilewitz also recently made the following trade(s):

  • On Monday, November 20th, Dale Danilewitz sold 4,459 shares of AmerisourceBergen stock. The stock was sold at an average price of $78.30, for a total transaction of $349,139.70.
  • On Monday, November 13th, Dale Danilewitz sold 1,857 shares of AmerisourceBergen stock. The shares were sold at an average price of $74.69, for a total transaction of $138,699.33.
  • On Thursday, November 2nd, Dale Danilewitz sold 2,012 shares of AmerisourceBergen stock. The shares were sold at an average price of $74.99, for a total transaction of $150,879.88.
  • On Thursday, October 5th, Dale Danilewitz sold 2,012 shares of AmerisourceBergen stock. The shares were sold at an average price of $85.00, for a total transaction of $171,020.00.

Shares of AmerisourceBergen Corp. (NYSE:ABC) traded down $0.31 on Thursday, reaching $97.21. 1,070,200 shares of the company’s stock traded hands, compared to its average volume of 1,411,743. The firm has a market capitalization of $21,230.00, a P/E ratio of 60.01, a price-to-earnings-growth ratio of 1.63 and a beta of 0.99. AmerisourceBergen Corp. has a 52 week low of $71.90 and a 52 week high of $97.86. The company has a current ratio of 0.91, a quick ratio of 0.48 and a debt-to-equity ratio of 1.83.

AmerisourceBergen (NYSE:ABC) last announced its earnings results on Thursday, November 2nd. The company reported $1.33 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.32 by $0.01. The company had revenue of $39.12 billion during the quarter, compared to the consensus estimate of $40.10 billion. AmerisourceBergen had a net margin of 0.27% and a return on equity of 56.29%. AmerisourceBergen’s revenue was up 4.2% compared to the same quarter last year. During the same period last year, the firm earned $1.30 earnings per share. research analysts anticipate that AmerisourceBergen Corp. will post 6.14 earnings per share for the current fiscal year.

Several large investors have recently bought and sold shares of ABC. Victory Capital Management Inc. lifted its stake in shares of AmerisourceBergen by 7.2% during the second quarter. Victory Capital Management Inc. now owns 38,045 shares of the company’s stock worth $3,596,000 after buying an additional 2,559 shares during the period. Delta Lloyd Asset Management N.V. acquired a new stake in shares of AmerisourceBergen during the second quarter worth $2,155,000. Pinnacle Associates Ltd. acquired a new stake in shares of AmerisourceBergen during the second quarter worth $203,000. Commonwealth of Pennsylvania Public School Empls Retrmt SYS lifted its stake in shares of AmerisourceBergen by 0.7% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 12,329 shares of the company’s stock worth $1,165,000 after buying an additional 80 shares during the period. Finally, Kayne Anderson Rudnick Investment Management LLC lifted its stake in shares of AmerisourceBergen by 5.5% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 44,785 shares of the company’s stock worth $4,234,000 after buying an additional 2,320 shares during the period. Institutional investors and hedge funds own 67.83% of the company’s stock.

ABC has been the topic of a number of recent research reports. Needham & Company LLC increased their price objective on shares of AmerisourceBergen from $86.00 to $88.00 and gave the company a “buy” rating in a research note on Wednesday, November 22nd. Robert W. Baird reiterated a “buy” rating and set a $96.00 price objective on shares of AmerisourceBergen in a research note on Monday, November 6th. Mizuho set a $92.00 price objective on shares of AmerisourceBergen and gave the company a “hold” rating in a research note on Tuesday, October 24th. Zacks Investment Research upgraded shares of AmerisourceBergen from a “hold” rating to a “buy” rating and set a $105.00 price objective on the stock in a research note on Wednesday, January 3rd. Finally, ValuEngine upgraded shares of AmerisourceBergen from a “hold” rating to a “buy” rating in a research note on Tuesday, October 31st. One analyst has rated the stock with a sell rating, seven have issued a hold rating, nine have given a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and an average price target of $95.96.

WARNING: This story was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another website, it was stolen and republished in violation of United States and international copyright and trademark laws. The correct version of this story can be viewed at https://www.dispatchtribunal.com/2018/01/11/amerisourcebergen-corp-abc-insider-dale-danilewitz-sells-3121-shares-of-stock.html.

About AmerisourceBergen

AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.

Insider Buying and Selling by Quarter for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply